| Ajanta Pharma Ltd |
|---|
| Registered Office: Ajanta House, Charkop Kandivli (W), Mumbai - 400067, Maharashtra |
| Phone: 91-22-66061000/1204/1203 |
| Email: info@ajantapharma.com; investorgrievance@ajantapha |
| Website: www.ajantapharma.com |
| Public issue of 30,13,759 equity shares of Rs 10 /- each,for cash at a premium of Rs 215 per share (i.e price of Rs 225 per equity share) aggregating Rs 67.81 crores. |
| Issue | Money Payable On | ||
|---|---|---|---|
| Opens On | Closes On | Application | Allotment |
| 23-Mar-2000 | 28-Mar-2000 | ₹ 125.00 | ₹ 100.00 |
| Minimum Application for shares in Nos : 100.0 Further Multiples of : 50.0 | ||
|---|---|---|
| (₹)Cr. | Lead Managers to the Issue | |
| Project Cost | 10.44 | ICICI Securities & Finance Company Ltd |
| Project Financed through Current Offer | 67.50 | |
| Post Issue Equity Share Capital | 11.82 | |
| Issue Price | ₹225.00 | |
| Projects |
|---|
| Expansion of facilities in the existing R&D Centre |
| Setting up a New Formulation Facilities |
| Upgrading Existing Herbal Extraction Pilot Plant |
| Promoted By |
|---|
| Purushottam Agrawal |
| Mannalal Agrawal |
| Madhusudan Agrawal |
| Listing At |
|---|
| BSE |
| NSE |
| Registrar to the Issue |
|---|
